Cirdan

Executive Summary

Cirdan is a UK-based laboratory informatics and digital pathology company founded in 1998. The company offers Laboratory Information Management Systems (LIMS/LIS) and digital tools to automate and streamline clinical and research laboratory workflows. By improving diagnostic efficiency and data management across the entire clinical pathway, Cirdan aims to enhance global patient wellbeing. With over two decades of experience, the company has established a strong presence in the diagnostics sector, serving clinical labs and research institutions. Cirdan's solutions are designed to integrate seamlessly into existing lab environments, reducing manual errors and accelerating turnaround times. The company's focus on digital pathology positions it well to benefit from the growing adoption of AI and digital tools in healthcare. Despite not disclosing funding or valuation, Cirdan's longevity and specialized niche suggest a stable, privately held operation with potential for steady growth.

Upcoming Catalysts (preview)

• Q2 2026Launch of Next-Generation LIMS Platform with AI Integration70% success
• Q3 2026Strategic Partnership with Major UK NHS Trust for Digital Pathology Rollout60% success
• Q4 2026Expansion into European Markets with CE Marking for New Diagnostic Software55% success